|
Q3 FY2026
As of Aug 28, 2026
|
Q2 FY2026
As of May 29, 2026
|
Q1 FY2026
As of Feb 27, 2026
|
Q4 FY2025
As of Nov 28, 2025
|
Q3 FY2025
As of Aug 29, 2025
|
Q2 FY2025
As of May 30, 2025
|
Q1 FY2025
As of Feb 28, 2025
|
Q4 FY2024
As of Nov 29, 2024
|
Q3 FY2024
As of Aug 30, 2024
|
Q2 FY2024
As of May 31, 2024
|
Q1 FY2024
As of Mar 1, 2024
|
Q4 FY2023
As of Dec 1, 2023
|
Q3 FY2023
As of Sep 1, 2023
|
Q2 FY2023
As of Jun 2, 2023
|
Q1 FY2023
As of Mar 3, 2023
|
Q4 FY2022
As of Dec 2, 2022
|
Q3 FY2022
As of Sep 2, 2022
|
Q2 FY2022
As of Jun 3, 2022
|
Q1 FY2022
As of Mar 4, 2022
|
Q4 FY2021
As of Dec 3, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Trade receivables, net of allowances for doubtful accounts of $12 and $13, respectively | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade payables | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; 2 shares authorized; none issued | ||||||||||||||||||||
| Common stock, $0.0001 par value; 900 shares authorized; 601 shares issued; 391 and 413 shares outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, at cost (148 and 146 shares, respectively) | ||||||||||||||||||||
| Treasury stock, at cost (210 and 188 shares, respectively) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
